[1]
|
Dellinger, R., Levy, M., Rhodes, A., et al. (2013) Surviving Sepsis Campaign: International Guidelines for the Manage-ment of Severe Sepsis and Septic Shock 2012. Critical Care Medicine, 41, 580-637.
https://doi.org/10.1097/CCM.0b013e31827e83af
|
[2]
|
Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analy-sis for the Global Burden of Disease Study. The Lancet, 395, 200-211. https://doi.org/10.1016/S0140-6736(19)32989-7
|
[3]
|
Torio, C.M. and Andrews, R.M. (2006) National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. Healthcare Cost and Utilization Project (HCUP) Statis-tical Briefs. Agency for Healthcare Research and Quality (US), Rockville (MD).
|
[4]
|
Rhee, C., Gohil, S. and Klompas, M. (2014) Regulatory Mandates for Sepsis Care—Reasons for Caution. The New England Journal of Medicine, 370, 1673-1376. https://doi.org/10.1056/NEJMp1400276
|
[5]
|
杨雪, 钱素云, 祝益民, 等. 连续血液净化技术在中国儿童重症医学科应用状况的横断面调查[J]. 中国循证儿科杂志, 2017, 12(5): 347-351.
|
[6]
|
Vincent, J.L. (2012) Increasing Awareness of Sepsis: World Sepsis Day. Critical Care, 16, Article No. 152.
https://doi.org/10.1186/cc11511
|
[7]
|
Monard, C., Rimmelé, T. and Ronco, C. (2019) Extracorporeal Blood Purifi-cation Therapies for Sepsis. Blood Purification, 47, 2-15. https://doi.org/10.1159/000499520
|
[8]
|
Ronco, C., Ricci, Z. and Husain-Syed, F. (2019) From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Blood Purification, 48, 99-105. https://doi.org/10.1159/000490694
|
[9]
|
Ankawi, G., Neri, M., Zhang, J., Breglia, A., Ricci, Z. and Ronco, C. (2018) Extracorporeal Techniques for the Treatment of Critically Ill Patients with Sepsis beyond Conventional Blood Purification Therapy: The Promises and the Pitfalls. Critical Care, 22, Article No. 262. https://doi.org/10.1186/s13054-018-2181-z
|
[10]
|
Clark, W.R., Ferrari, F., La Manna, G. and Ronco, C. (2017) Extracorporeal Sorbent Technologies: Basic Concepts and Clinical Application. In: La Manna, G. and Ronco, C., Eds., Contributions to Nephrology, Karger Publishers, Basel, 43-57.
https://doi.org/10.1159/000468911
|
[11]
|
Ronco, C., Bordoni, V. and Levin, N.W. (2002) Adsorbents: From Basic Structure to Clinical Application. Contributions to Nephrology, 137, 158-164.
|
[12]
|
Cole, L., Bellomo, R., Hart, G., et al. (2002) A Phase II Randomized, Controlled Trial of Continuous Hemofiltration in Sepsis. Critical Care Medicine, 30, 100-106. https://doi.org/10.1097/00003246-200201000-00016
|
[13]
|
Payen, D. and Mateo, J. (2009) Impact of Continuous Venovenous Hemofiltration on Organ Failure during the Early Phase of Severe Sepsis: A Randomized Con-trolled Trial. Critical Care Medicine, 37, 803-810.
https://doi.org/10.1097/CCM.0b013e3181962316
|
[14]
|
Sun, Z.P., Ye, H., Shen, X., et al. (2014) Continuous Venovenous Hemofiltration versus Extended Daily Hemofiltration in Patients with Septic Acute Kidney Injury: A Retro-spective Cohort Study. Critical Care, 18, Article No. R70.
https://doi.org/10.1186/cc13827
|
[15]
|
闫婷, 李双玲, 王东信, 等. 间歇性高容量血液滤过对严重感染和感染性休克患者治疗效果的影响[J]. 中国危重病急救医学, 2013, 25(1): 19-23.
|
[16]
|
边雅荣. 在重症感染性休克急诊救治护理中早期应用血滤机进行高容量血液滤过的效果观察[J]. 微量元素与健康研究, 2023, 40(1): 92-93.
|
[17]
|
田淼. 高容量血液滤过对重症感染性休克患者脏器功能及预后的影响[J]. 大医生, 2022, 7(24): 93-95.
https://doi.org/10.19604/j.cnki.dys.2022.24.031
|
[18]
|
管向东, 张晔. 连续血液净化技术在重症医学科中的地位[J]. 中华重症医学电子杂志, 2017, 3(1): 2-4.
|
[19]
|
Li, W.H., Yin, Y.M., Chen, H., Wang, X.D., Yun, H., Li, H., Luo, J. and Wang, J.W. (2017) Curative Effect of Neutral Macroporous Resin Hemoperfusion on Treating Hemodialysis Patients with Refractory Uremic Pruritus. Medicine, 96, e6160. https://doi.org/10.1097/MD.0000000000006160
|
[20]
|
Morachiello, P., Landini, S., Fracasso, A., Righetto, F., Scanferla, F., Toffoletto, P., Genchi, R. and Bazzato, G. (1991) Combined Hemodialysis-Hemoperfusion in the Treat-ment of Secondary Hyperparathyroidism of Uremic Patients. Blood Purification, 9, 148-152. https://doi.org/10.1159/000170011
|
[21]
|
Cruz, D.N., Perazella, M.A., Bellomo, R., et al. (2007) Effectivness of Polymyxin B-Immobilized Fiber Column in Sepsis: A Systematic Review. Critical Care, 11, Article No. R47. https://doi.org/10.1186/cc5780
|
[22]
|
Cruz, D.N., Antonelli, M., Fumagalli, R., et al. (2009) Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock. JAMA, 301, 2445-2452. https://doi.org/10.1001/jama.2009.856
|
[23]
|
Payen, D., Guilbert, J., Launey, Y., et al. (2015) Early Use of Poly-myxin B Hemoperfusion in Patients with Septic Shock Due to Peritonitis: A Multicentre Randomized Control Trial. In-tensive Care Medicine, 41, 975-984.
https://doi.org/10.1007/s00134-015-3751-z
|
[24]
|
Nassiri, A.A., Hakemi, M.S., Miri, M.M., Shahrami, R., Koomleh, A.A. and Sabaghian, T. (2021) Blood Purification with CytoSorb in Critically Ill COVID-19 Patients: A Case Series of 26 Patients. Artificial Organs, 45, 1338-1347.
https://doi.org/10.1111/aor.14024
|
[25]
|
Paul, R., Sathe, P., Kumar, S., Prasad, S., Aleem, M. and Sakhalvalkar, P. (2021) Multicentered Prospective Investigator Initiated Study to Evaluate the Clinical Outcomes with Extracorporeal Cy-tokine Adsorption Device (CytoSorb) in Patients with Sepsis and Septic Shock. World Journal of Critical Care Medicine, 10, 22-34.
https://doi.org/10.5492/wjccm.v10.i1.22
|
[26]
|
Alharthy, A., Faqihi, F. and Memish, Z.A. (2021) Continuous Renal Replacement Therapy with the Addition of CytoSorb Cartridge in Critically Ill Patients with COVID-19 plus Acute Kid-ney Injury: A Case-Series. Artificial Organs, 45, E101-E112. https://doi.org/10.1111/aor.13864
|
[27]
|
Brouwer, W.P., Duran, S., Kuijper, M. and Ince, C. (2019) Hemoadsorption with CytoSorb Shows a Decreased Observed versus Expected 28-Day All-Cause Mortality in ICU Patients with Septic Shock: A Propensity-Score-Weighted Retrospective Study. Critical Care, 23, Article No. 317. https://doi.org/10.1186/s13054-019-2588-1
|
[28]
|
Schädler, D., Pausch, C., Heise, D., et al. (2017) The Effect of a Novel Extracorporeal Cytokine Hemoadsorption Device on IL-6 Elimination in Septic Patients: A randomized Controlled Trial. PLOS ONE, 12, e0187015.
https://doi.org/10.1371/journal.pone.0187015
|
[29]
|
Esmaeili Vardanjani, A., Ronco, C., et al. (2021) Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19. Blood Purification, 50, 257-260.
https://doi.org/10.1159/000509107
|
[30]
|
Sazonov, V., Abylkassov, R., Tobylbayeva, Z., Saparov, A., Mironova, O. and Poddighe, D. (2021) Case Series: Efficacy and Safety of Hemoadsorption with HA-330 Adsorber in Septic Pediatric Patients with Cancer. Frontiers in Pediatrics, 9, Article 672260. https://doi.org/10.3389/fped.2021.672260
|
[31]
|
Huang, Z., Wang, S., Su, W. and Liu, J.Y. (2010) Removal of Humoral Mediators and the Effect on the Survival of Septic Patients by Hemoperfusion with Neutral Microporous Resin Column. Therapeutic Apheresis and Dialysis, 14, 596-602. https://doi.org/10.1111/j.1744-9987.2010.00825.x
|
[32]
|
Huang, Z., Wand, S., Yang, Z. and Liu, J. (2013) Effect on Extrapulmonary Sepsis-Induced Acute Lung Injury by Hemoperfusion with Neutral Microporous Resin Column. Ther-apeutic Apheresis and Dialysis, 17, 454-461.
https://doi.org/10.1111/j.1744-9987.2012.01083.x
|
[33]
|
Chu, L., Li, G., Yu, Y., et al. (2020) Clinical Effects of Hemoperfusion Combined with Pulse High-Volume Hemofiltration on Septic Shock. Medicine, 99, e19058. https://doi.org/10.1097/MD.0000000000019058
|